Journal of Thoracic Oncology Oncology
Final Analysis From PECATI Phase 2 Trial: Lenvatinib in Combination With Pembrolizumab in Pretreated Advanced B3 Thymoma and Thymic Carcinoma
The publisher did not provide an abstract — full text is available via the link below.